Abstract
Compared with normal control groups, the endometrial microbiota of infertile patients with chronic endometritis (CE) or endometrial polyps (EP) exhibits significant changes in the relative abundance distribution of bacterial species. These findings suggest that changes in local microecology may be a critical factor in the occurrence of these diseases and subsequent adverse pregnancy outcomes. Further study of endometrial microecology may provide new opportunities to improve diagnosis and treatment strategies for chronic endometritis.
Introduction
Infertility is often a "silent" struggle, frequently linked to asymptomatic conditions like chronic endometritis (CE)—a persistent inflammation of the uterine lining—and endometrial polyps (EP). Historically, the uterus was thought to be sterile, but modern molecular techniques have revealed a complex resident microbiota.
The challenge lies in the fact that CE is notoriously difficult to diagnose due to its lack of clear symptoms, leading to inconsistent treatments and poor outcomes in assisted reproductive technology (ART). This study seeks to bridge the gap by characterizing how the microbial landscape shifts across the vaginal, cervical, and uterine environments in women with these conditions, potentially identifying microbial "signatures" that could improve diagnosis and treatment.
Methods
The researchers conducted a prospective study of 134 asymptomatic infertile patients undergoing ART. They collected samples from three distinct sites to observe the microbial continuum: the Vaginal Microbiome (VM), Cervical Microbiome (CM), and Endometrial Microbiome (EM).
The core technique used was 16S ribosomal RNA (16S rRNA) sequencing (specifically the V4 region), which allows for the identification of bacterial genera based on genetic "barcodes." Patients were categorized into three groups based on pathological examination and immunohistochemistry (looking for CD38/CD138 markers): Chronic Endometritis (CE, n=29), Endometrial Polyps (EP, n=20), and Normal Endometrium (NE, n=85).
The Microbiota Continuum
The study confirms that the female genital tract is not a series of isolated compartments but a continuum. Bacterial abundance decreases from the vagina to the uterus, while diversity actually increases as you move upward. In healthy states, Lactobacillus dominates the entire tract. However, in patients with CE and EP, this dominance is significantly eroded, particularly in the uterine cavity, making room for opportunistic pathogens.
Key Insights and Results
Pathogenic Clusters
The researchers identified a "who's who" of bacteria associated with uterine disease. Genera such as Staphylococcus, Gardnerella, Atopobium, Streptococcus, Peptostreptococcus, Chlamydia, Fusobacterium, and Acinetobacter were significantly more prevalent in the CE and EP groups. Interestingly, Chlamydia and Fusobacterium showed high abundance specifically in the cervix of CE patients, suggesting these sites might act as reservoirs for bacteria that eventually migrate to the endometrium.
Taxonomic and Diversity Shifts
- Diversity: The NE (normal) group had higher overall species richness in the uterine cavity than the disease groups, suggesting that a healthy uterus maintains a diverse but stable "native" population that is disrupted during disease.
- Phylum Level: In the CE group, the phylum Firmicutes increased significantly across the tract, while Proteobacteria decreased in the endometrium.
- Clinical Correlation: The presence of Porphyromonas and Escherichia was highly correlated with the occurrence of CE, while Peptostreptococcus and Pseudomonas were more closely linked to EPs.
Discussion and Future Directions
While this study provides a solid characterization of 134 patients, the authors acknowledge limitations, including the relatively small size of the EP group and the genus-level resolution of 16S rRNA sequencing. Furthermore, the "chicken or egg" problem remains: it is unclear if the altered microbiota causes the polyps and inflammation, or if the diseased tissue provides a niche that allows these bacteria to thrive.
Future research should focus on longitudinal studies to determine if correcting the microbiota via antibiotics or probiotics directly improves pregnancy rates in infertile women. Understanding these microbial shifts offers a new opportunity to refine diagnosis and treatment strategies for chronic endometritis and endometrial polyps.
Summary updated